Brean Murray downgrades CardioNet (Nasdaq: BEAT) from Buy to Hold.

Brean analyst says, "While we are long-term believers in telemetry-based ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE